DIET IN GOUT AND HYPERURICEMIA

by O. V. Zhelyabina, M. S. Eliseev
Published 2017-09-01

Practical application of national clinical guidelines for the management of gout (preliminary data)

by M. N. Chikina, M. S. Eliseev, O. V. Zhelyabina
Published 2020-05-01

Impact of urate-lowering therapy on quality of life indicators in patients with gout

by M. N. Chikina, O. V. Zhelyabina, M. S. Eliseev
Published 2021-06-01

Assessment of cardiovascular risk from the use of an interleukin-1 inhibitor in patients with severe tophaceous gout

by M. S. Eliseev, O. V. Zhelyabina, E. I. Markelova, D. S. Novikova, S. A. Vladimirov, Yu. O. Korsakova, E. N. Aleksandrova, A. A. Novikov, E. L. Nasonov
Published 2016-03-01

Comparison of the efficacy and safety of various anti-inflammatory drugs in urate-lowering therapy initiation in patients with gout (preliminary data)

by M. N. Chikina, M. S. Eliseev, O. V. Zhelyabina
Published 2021-04-01

Urate-lowering therapy for heart failure

by O. V. Zhelyabina, M. S. Eliseev
Published 2019-09-01

Clinical experience with the interleukin-1β blocker canakinumab in patients with chronic tophaceous gout: abolishment of arthritis and prevention of exacerbations when allopurinol is used

by M. S. Eliseev, O. V. Zhelyabina, M. V. Mukagova, E. L. Nasonov
Published 2015-06-01

Xanthine oxidase inhibitors in asymptomatic hyperuricemia

by O. V. Zhelyabina, M. S. Eliseev
Published 2019-10-01

Assessment of cardiovascular risk in patients with crystal-induced arthritides and rheumatoid arthritis by the ATP III and Reynolds Risk Score

by M. S. Eliseev, A. M. Novikova, O. V. Zhelyabina, E. V. Gerasimova, E. V. Ilyinykh, T. V. Popkova, T. S. Panevin, E. L. Nasonov
Published 2020-11-01

Some opportunities of using xanthine oxidase inhibitors

by O. V. Zhelyabina, M. S. Eliseev
Published 2019-03-01

Age-related features of calcium pyrophosphate deposition disease

by M. S. Eliseev, O. V. Zhelyabina, M. N. Chikina
Published 2019-12-01